By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ophthotech Corporation 

5 Vaughn Drive
Suite 106
Princeton  New Jersey  08540  U.S.A.
Phone: 609-945-6050 Fax: 609-452-7435


Company News
Ophthotech Corporation (OPHT) Names Todd N. Smith As Chief Commercial Officer 10/3/2014 8:15:34 AM
Ophthotech Corporation (OPHT) Names Michael G. Atieh As Executive Vice President And Chief Financial And Business Officer 9/23/2014 9:49:10 AM
Ophthotech Corporation (OPHT) Announces Fovista® Phase 2b Independent Analysis Shows That Fovista® Anti-PDGF Therapy, Combined With Anti-VEGF Therapy, Is Associated With A Reduction Of Sub-Retinal Fibrosis In Wet AMD Patients 9/16/2014 9:12:28 AM
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014 6:05:20 AM
Ophthotech Corporation (OPHT) To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 1:41:48 PM
Ophthotech Corporation (OPHT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/6/2014 9:24:19 AM
Ophthotech Corporation (OPHT) Initiates First Of Several Expansion Studies To Further Evaluate Fovista® (Anti-PDGF) Therapy In Patients With Wet Age-Related Macular Degeneration 8/5/2014 10:45:41 AM
Ophthotech Corporation (OPHT) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/29/2014 9:38:46 AM
Ophthotech Corporation (OPHT) May Pocket $1 Billion From Eye Drug Deal With Novartis AG (NVS), Ophthotech Stock Up +24.48% At Market Close (May 20, 2014) 5/20/2014 7:14:39 AM
Ophthotech Corporation (OPHT) Reports First Quarter 2014 Financial Results And Provides Business Update 5/13/2014 7:24:17 AM